Fox & Mandal represented Pulsar Capital-owned TruDoc Healthcare (TruDoc), a UAE-based virtual healthcare provider, in its 100 per cent acquisition of Wellthy Therapeutics, Asia's leading chronic disease management platform.
This acquisition deal of TruDoc and Wellthy Therapeutics is expected to empower multiple stakeholders including insurers, employers, and governments to deliver high-quality, personalized care. This integration ensures round-the-clock access to high-quality care, tailored treatment plans, and innovative care delivery methods for patients.
These advancements hold the potential to greatly enhance health results and streamline healthcare expenditures. With TruDoc's leadership in the GCC and Wellthy's proven track record in Asia, this alliance is poised to reinforce TruDoc's leading position in the region as a tech-enabled primary care provider.
This strategic partnership signifies a significant step towards closing the loop on full stack primary care, leveraging TruDoc's clinical proficiency and Wellthy Therapeutics' prowess in digital health and behavioral science.
The Fox & Mandal team representing TruDoc in this transaction was led by Partner & Head of Corporate Practice, Akshat Pande and included Associates, Sadhak Sharma, Anuja Khandelwal and Avneesh Bahuguna.
About Fox & Mandal Corporate Practice:
Fox & Mandal Corporate-M&A practice provides a whole suite of offerings for the entire life cycle of a business venture, spanning from inception of the entity, providing day-to-day advisory support through its development and maturation, and even when clients require it to be wound up. The firm offers services for mergers and acquisitions, de-mergers, joint ventures and strategic alliances, investment and fundraising including private equity and venture capital investments, corporate restructuring, vendor contracts distributorship and franchise agreements, and security laws.
Disclaimer: The above deal report is published as received from the concerned firm and does not necessarily represent or reflect the views of this publishing house.